Riboxinum - a drug that stimulates the metabolism of the cells by increasing their energy potential. Especially effective Riboxinum acts on the cells of the heart muscle (myocardium), so it is often prescribed for coronary heart disease and other cardiovascular diseases.
The mechanism of action Riboxin
Riboxinum (INN - inosine) - is a drug belonging to the group means of normalizing the metabolism in tissues and reducing myocardial oxygen deprivation (hypoxia) tissues. Riboxinum discharged into tablets of 200 mg and a 2% solution in 10 ml ampoules for intravenous administration. Various pharmaceutical companies produced analogues Riboxin: inosine and ribonozin.
Riboksina mechanism of action is based on the fact that it is a nucleoside, i.e. precursor energy source ATP. How nucleoside Riboxinum easily penetrates into cells, increasing their energy balance and stimulating the synthesis of nucleotides. Especially effective Riboxinum acts on the cells of the myocardium and liver, improving metabolic processes in them. By activating the metabolism (especially glucose metabolism
Glucose: The energy source
, Which resulted in the release of energy) of myocardial cells are easier to tolerate the lack of oxygen (hypoxia), they restored the normal conduction of electrical impulses, which helps to restore heart rhythm.
Riboxinum also improves myocardial arterial blood supply, restores normal blood flow in the kidney, impaired following surgery on this organ. The process of tissue respiration is also improved by enhancing the exchange of pyruvic acid. It reduced the ability of blood to the blood clots.
Riboksina general effect is to increase the contractility of the myocardium, its more complete relaxation during diastole and increased stroke volume. In addition, under the influence of Riboxin improved recovery of the heart muscle after myocardial infarction. This action helps to prevent the development of chronic cardiovascular disease and the development of thromboembolism. Also improved regeneration of gastric mucosa after erosive and ulcerative lesions and liver condition in all its diseases.
Indications for use
Riboxinum used primarily in cardiovascular diseases. So, it is widely used in coronary heart disease (CHD). This disease is characterized by impaired coronary circulation due to the fact that the clearance reduces atherosclerotic plaques of the coronary arteries. An extreme manifestation of coronary heart disease is a heart attack - necrosis of myocardial tissue. Under the action riboksina it improves myocardial metabolism, which in turn increases the tolerability of myocardial hypoxia, that is, prevents the development of myocardial infarction. And if you still infakrkt infarction occurred Riboxinum contributes to the rapid recovery of heart function.
In addition, Riboxinum prescribed for heart defects (congenital or acquired), inflammatory and metabolic disorders in the myocardium (myocarditis and myocardial), as well as adults, in developing on the background of cardiac glycosides.
Will Riboxinum in acute and chronic hepatitis, liver cirrhosis of any origin, fatty liver and other diseases. Under the influence of Riboxin improved function of hepatocytes - the liver cells.
In gastric ulcer and duodenal ulcer Riboxinum prevents exacerbation and contributes to a more rapid conclusion.
Used Riboxinum well as urokoproporfirii - cutaneous porphyria, is characterized by impaired metabolism of porphyrins, which are being postponed in the skin to cause sensitization to the sun, and increased sensitivity to mechanical stimulation. The disease is dysfunction of the liver enzyme responsible for the synthesis and exchange of porphyrins. To improve the condition of the liver cells, and thus the condition of these patients could use Riboxin.
Under the influence riboksina faster the healing of radiation burns, and there is no reduction in the number of leukocytes in the blood. With open-angle glaucoma
Open-angle glaucoma - occurs often goes unnoticed
Riboxinum improves vision.
Side effects and contraindications Riboxin for its reception
Riboxinum generally well tolerated, but sometimes in the background of his admission there are attacks of palpitations, there is redness and itching of the skin, increased uric acid in the blood and increase gout. And possible allergic reactions.
Application Riboxin contraindicated in gout, elevated levels of uric acid in the blood, intolerance of simple sugars (glucose, fructose, sucrose), as well as hypersensitive to the components of the drug. Riboxinum in vials is contraindicated in pregnancy, breast-
Breastfeeding - a personal choice
chest and under the age of 18 years - the use of the drug in these patient groups has not been confirmed by clinical studies.
With careful use Riboxinum with severe renal impairment and diabetes.
Riboxinum improves metabolism
Improves metabolism and losing weight without dieting
in cells, and thus the condition of an organ as a whole.
Galina Romanenko